Ventricular Tachycardia clinical trials at UCSD
3 in progress, 1 open to eligible people
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study
open to eligible people ages 18 years and up
This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.
San Diego, California and other locations
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
Sorry, not currently recruiting here
Medtronic is sponsoring the Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS) to further confirm safety and effectiveness of ventricular iATP therapy in routine clinical practice, following commercial release of iATP-capable devices. The iATP PAS is conducted within Medtronic's Product Surveillance Registry platform (NCT01524276).
Chula Vista, California and other locations
Vektor vMap™ Clinical Validation Study
Sorry, not yet accepting patients
This is a retrospective, multi center clinical study collecting existing, de-identified subject data from medical records to be analyzed using an independent core laboratory to validate performance of a computational ECG mapping system (vMap™).
La Jolla, California and other locations
Last updated: